Sienna Receives $638K in R&D Tax Incentive Funding

13-Oct-2016 Sienna today reported the receipt of $637,524 from the R & D Tax Incentive program for the 2016 financial year.  During this time Sienna’s R&D team advanced their telomerase-detection technology by conducting important clinical studies, developing manufacturing processes, and conducting critical verification, validation, and stability testing in preparation for product registration with regulatory authorities across the world.

Sienna’s CFO, Tony Di Pietro, commented ‘the receipt of these non-dilutive funds will go towards Sienna’s efforts to register an IVD product, further penetrate the USA, and enter the European diagnostic market."


No Very

Captcha Image

Sign up for updates